Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States

Clinical Therapeutics

Volumn 31, Issue 11, 2009, Pages 2608-2617

  Koro, Carol E ^a   Lee, Bo Hyen ^a   Bowlin, Steve J ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

antidiabetic medication; chronic kidney disease; diabetes mellitus; NHANES IV; type 2

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALBUMIN; ALPHA GLUCOSIDASE INHIBITOR; CREATININE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MEGLITINIDE; METFORMIN; ORAL ANTIDIABETIC AGENT; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ALBUMINURIA; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG UTILIZATION; FEMALE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEALTH SURVEY; HUMAN; IMMUNOFLUORESCENCE TEST; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RACE DIFFERENCE; SAMPLE SIZE; SELF REPORT; SEX RATIO; UNITED STATES;

ADULT; AGED; BLOOD GLUCOSE; CHRONIC DISEASE; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; DRUG UTILIZATION; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 74549133127     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.10.020     Document Type: Article

References (20)

1. Healthy People 2010. Chronic kidney disease. http://www.healthypeople.gov/Document/HTML/Volume1/04CKD.htm Accessed March 25, 2008
2. Narva A.S., and Kuracina T.A. Chronic kidney disease: Definition and classification. http://www.ihs.gov/medicalprograms/kidney/pro_clinicaltools/CKDDefinitionandClassification.pdf Accessed March 25, 2008
3. National Kidney Foundation. Diabetes and chronic kidney disease: Stages 1-4. http://www.kidney.org/atoz/pdf/diabetes.pdf Accessed March 25, 2008
4. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 Suppl 1 (2002) S1-S266
5. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047
6. Selvin E., Manzi J., Stevens L.A., et al. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis 50 (2007) 918-926
7. Levey A.S., Bosch J.P., Lewis J.B., et al., Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130 (1999) 461-470
8. Levey A.S., Coresh J., Greene T., et al., Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate [published correction appears in Ann Intern Med. 2008;149:519]. Ann Intern Med 145 (2006) 247-254
9. Centers for Disease Control and Prevention (CDC). National health and nutrition examination survey codebook for data production (2005-2006). http://www.cdc.gov/NCHS/data/nhanes/nhanes_05_06/ghb_d.pdf Accessed May 1, 2009
10. Retnakaran R., Cull C.A., Thorne K.I., et al., UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes: UK Prospective Diabetes Study 74. Diabetes 55 (2006) 1832-1839
11. Lin C.H., Yang W.C., Tsai S.T., et al. A community-based study of chronic kidney disease among type 2 diabetics in Kinmen, Taiwan. Diabetes Res Clin Pract 75 (2007) 306-312
12. Naushahi M.J., de Grauw W.J., Avery A.J., et al. Risk factors for development of impaired renal function in type 2 diabetes mellitus patients in primary care. Diabet Med 21 (2004) 1096-1101
13. American Diabetes Association. Standard of medical care in diabetes-2008. Diabetes Care 31 Suppl 1 (2008) S12-S54
14. Cavanaugh K.L. Diabetes management issues for patients with chronic kidney disease. Clin Diabetes 25 (2007) 90-97
15. KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 49 Suppl 2 (2007) S12-S154
16. Actos (pioglitazone hydrochloride) tablets [prescribing information]. http://www.actos.com/actos/prescribinginfo.aspx Accessed August 26, 2008
17. Avandia (rosiglitazone maleate) tablets [prescribing information]. http://us.gsk.com/products/assets/us_avandia.pdf Accessed August 26, 2008
18. Krentz A.J., and Bailey C.J. Oral antidiabetic agents: Current role in type 2 diabetes mellitus. Drugs 65 (2005) 385-411
19. Thompson-Culkin K., Zussman B., Miller A.K., and Freed M.I. Pharmacokinetics of rosiglitazone in patients with end-stage renal disease. J Int Med Res 30 (2002) 391-399
20. Chapelsky M.C., Thompson-Culkin K., Miller A.K., et al. Pharmacokinetics of rosiglitazone in patients with varying degrees of renal insufficiency. J Clin Pharmacol 43 (2003) 252-259